I have.
In response to @Mugpunter10 and YF's words:
Still believes it will be successful means it hasn't been successful yet, the IV arm is reaching significant dosage levels now.
YF can say with certainty that CF33 is killing cancer, but lots of drugs kill cancer, the question is how well does it do it and what are the benefits of using the drug on its own merits?
Much like her-vaxx provides an OS above current standard of care, but clearly not enough to be worth the trouble.
Where does CF33 fit on the scale?
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration, page-152
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.5¢ | $379.9K | 6.840M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 1581916 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 680013 | 6 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |